Articles and Blogs

A new report from Silicon Valley Bank analyzes the state of the health care technology market. The top U.S. regions for health care technology companies are New York, San Francisco, Massachusetts, Austin and Nashville. Nearly half of all health technology investments this year have gone to AI companies. Executives at several health systems announced... READ MORE

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework. Hall Render’s PE team of attorneys and advisors leverage... READ MORE

The government lawsuit against defendants Precision Lens and its founder Paul Ehlen, United States ex rel. Fesenmaier v. Cameron-Ehlen Group, Inc. (“Fesenmaier”), has garnered substantial media attention. This is due in part to juicy facts (kickbacks to physicians in such forms as fancy meals and exclusive vacations for which physicians were invoiced at below... READ MORE

In August 2023, the U.S. Food and Drug Administration (“FDA”) issued two compliance policies that outlined its strategy for enforcing the drug distribution security requirements established by the Drug Supply Chain Security Act (“DSCSA”), which were set to take effect on November 27, 2023. To support trading partners in meeting these requirements, FDA implemented... READ MORE

Goldner Capital Management, a private equity firm once prominent in the SNF sector, has filed for Chapter 11 bankruptcy, attributing a Covid-era lending scheme. Goldner claims an affiliate of one of its lenders leased or subleased 20 Goldner facilities and then stopped paying rent, causing a lease default that allowed the lender to seize... READ MORE

NATIONAL 5 hospitals, health systems facing Stark law allegations BCBSA antitrust lawsuit reaches $2.8B tentative settlement CMS sets Medicare appeal pathway for hospital designations Diabetes advocates back FTC lawsuit against PBMs Feds Say EMTALA Trumps Idaho Abortion Ban In Emergencies FTC lays out final rule on merger filings FTC increases premerger notification requirements despite... READ MORE

The Department of Health and Human Services Office of Inspector General (“OIG”) released a report on September 24, 2024, identifying the need for further oversight of remote patient monitoring (“RPM”) services. Notably, OIG is specifically recommending the use of incident-to modifiers, which will likely impact non-RPM services as well, and including ordering on the... READ MORE

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework. Hall Render’s PE team of attorneys and advisors leverage... READ MORE

In what has now become a common mash-up of celebrity influence and pharmaceutical marketing, a recent direct-to-consumer (“DTC”) television advertisement ( “TV Ad”) came under fire from the Food and Drug Administration’s (“FDA”) Office of Prescription Drug Promotion (“OPDP” or “agency”) in the agency’s fourth Untitled Letter of the year. With only three months... READ MORE

On October 3, 2024, the Centers for Medicare & Medicaid Services (“CMS”) published an interim final rule that eliminated the low wage index hospital policy and related budget neutrality adjustments. This action was prompted by the D.C. Circuit Court of Appeals’ decision to vacate the policy in Bridgeport Hospital v Becerra (“Bridgeport“) concluding that the... READ MORE